Biocorrx Inc. (OTCMKTS:BICX) Short Interest Update

Biocorrx Inc. (OTCMKTS:BICX) was the target of a significant decline in short interest during the month of July. As of July 31st, there was short interest totaling 543 shares, a decline of 68.8% from the July 15th total of 1,741 shares. Based on an average trading volume of 15,973 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company’s shares are short sold.

Biocorrx Stock Performance

Shares of BICX opened at $0.28 on Friday. Biocorrx has a twelve month low of $0.20 and a twelve month high of $1.28. The company has a market cap of $8.33 million, a P/E ratio of -1.75 and a beta of 0.19. The company’s fifty day simple moving average is $0.32 and its 200-day simple moving average is $0.35.

Biocorrx (OTCMKTS:BICX) last released its earnings results on Friday, May 15th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.06) by $0.03. The firm had revenue of $0.21 million during the quarter, compared to the consensus estimate of $0.22 million.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.